Streetbeat News

Regulatory

AUPH

GS

NKE

SGTX

TSLA

US stocks traded mixed with Dow Jones gaining and NASDAQ remaining unchanged. Top trending stocks included Aurinia Pharmaceuticals, Nike, Tesla, Goldman Sachs Group, and Sigilon Therapeutics. Aurinia is exploring strategic alternatives including a potential sale or merger. Nike reported a 10% YoY increase in Q4 revenue. Tesla may have had a strong Q2 in Australia. Goldman Sachs rose after clearing Federal Reserve's stress tests. Sigilon's shares skyrocketed after Eli Lilly agreed to acquire the company.

Portfolio Pulse from Benzinga Newsbot

June 30, 2023 | 1:01 am

TRVI

Trevi Therapeutics has filed for a mixed shelf offering of up to $200 million. The filing was made with the SEC and the details can be found on their website.

Portfolio Pulse from Charles Gross

June 29, 2023 | 9:10 pm

UNCY

Unicycive Therapeutics has been asked by the FDA to provide additional information on its Lanthanum Dioxycarbonate program. The request came after the FDA reviewed a study report submitted by the company, which showed no evidence of gastrointestinal neoplasms in mice. The FDA noted quantitative differences in the GI adverse findings observed with Lanthanum Dioxycarbonate compared to Lanthanum Carbonate.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 9:07 pm

FB

Meta Platforms Inc. is planning to allow users in the European Union to download apps through Facebook. This move is seen as a way to bypass app stores and their associated fees.

Portfolio Pulse from Charles Gross

June 29, 2023 | 9:06 pm

ASML

FXI

SPY

The U.S. government is expected to restrict exports of certain Dutch semiconductor manufacturing equipment to specific facilities in China. The move is likely to affect ASML, a Dutch company that is a leading supplier of photolithography systems for the semiconductor industry.

Portfolio Pulse from Charles Gross

June 29, 2023 | 9:01 pm

AMZN

Amazon is hiring numerous former Federal Trade Commission (FTC) officials in preparation for an impending antitrust lawsuit. The company has already hired around a dozen former FTC officials, including former FTC attorneys Brian Huseman, Amy Posner, and Sean Pugh. The FTC has already filed three lawsuits against Amazon and is expected to file an antitrust suit aiming to break up the company in the coming weeks.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 8:46 pm

NKLA

Nikola Corporation has received a written notice from Nasdaq stating that it has regained compliance with the listing rule, according to a recent filing.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:36 pm

MRUS

Merus shares are trading higher after the FDA granted Breakthrough Therapy Designation to zenocutuzumab for the treatment of NRG1+ pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:32 pm

MRUS

Merus has announced that its drug Zenocutuzumab has been granted Breakthrough Therapy Designation by the FDA for NRG1+ Pancreatic Cancer. This could potentially expedite the drug's development and review process.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:31 pm

PTCT

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that the MIT-E trial of vatiquinone for the treatment of mitochondrial disease associated seizures (MDAS) failed to achieve its primary endpoint of reduction in observable motor seizures. However, the study showed evidence of treatment effect in reducing seizure frequency in the overall study population and in the largest subgroup of children with Leigh syndrome. The company plans to discuss the results of the MOVE-FA trial of vatiquinone for the treatment of Friedreich ataxia with regulatory authorities.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 8:31 pm